Article info
PDFFeature article
Addressing ethical challenges in HIV prevention research with people who inject drugs
- Correspondence to Dr Liza Dawson, Division of AIDS, NIH/NIAID, 5601 Fisher's Lane, Room 9G48, Bethesda, MD 20892, USA; dawsonl{at}niaid.nih.gov
Citation
Addressing ethical challenges in HIV prevention research with people who inject drugs
Publication history
- Received May 14, 2015
- Revised March 23, 2016
- Accepted April 4, 2016
- First published April 25, 2016.
Online issue publication
February 24, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Is the promise of methadone Kenya’s solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study
- A police education programme to integrate occupational safety and HIV prevention: protocol for a modified stepped-wedge study design with parallel prospective cohorts to assess behavioural outcomes
- HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy
- Young and invisible: a qualitative study of service engagement by people who inject drugs in India
- Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
- Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis
- Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
- Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks
- Peer-mediated HIV assisted partner services to identify and link to care HIV-positive and HCV-positive people who inject drugs: a cohort study protocol
- Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol